A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 96



John R McLaughlin, Harvey A Risch, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry Lynch, Beth Karlan, David Fishman, Barry Rosen, Susan L Neuhausen, Kenneth Offit, Noah Kauff, Susan Domchek, Nadine Tung, Eitan Friedman, William Foulkes, Ping Sun, Steven A Narod. Lancet Oncol 2007
Times Cited: 140




List of shared articles



Times cited

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487

Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways.
Theresa Austria, Christine Marion, Vanessa Yu, Martin Widschwendter, David R Hinton, Louis Dubeau. Int J Cancer 2018
4

Modifiers of breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers.
Roger L Milne, Antonis C Antoniou. Endocr Relat Cancer 2016
35

Alternatives to risk-reducing surgery for ovarian cancer.
A Gadducci, C Sergiampietri, R Tana. Ann Oncol 2013
13



Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
153


A comprehensive approach to the identification and management of the BRCA patient.
Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
3

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.
Angiolo Gadducci, Nicoletta Biglia, Stefania Cosio, Piero Sismondi, Andrea Riccardo Genazzani. Gynecol Endocrinol 2010
18

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Dimitrios H Roukos, Evangelos Briasoulis. Nat Clin Pract Oncol 2007
90


Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.
Kelsey E Lewis, Karen H Lu, Amber M Klimczak, Samuel C Mok. Cancers (Basel) 2018
12

The clinical management of BRCA1 and BRCA2 mutation carriers.
Anthony P Gulati, Susan M Domchek. Curr Oncol Rep 2008
11